Healthcare Sales & Marketing Network News: Endogenous Tissue Restoration

Searching News Database: Endogenous Tissue Restoration

HSMN NewsFeed - 17 Jul 2025
Xeltis Announces Positive Data for Xabg, its Coronary Artery Bypass Conduit, in EU Clinical Trial
Devices Surgery Cardiology

HSMN NewsFeed - 5 Nov 2024
Xeltis expands leadership team with appointment of Luc Verhees as Vice President of Clinical Business Development
Devices Personnel

HSMN NewsFeed - 13 Jun 2024
Xeltis receives IDE approval from FDA for initiation of US pivotal trial for aXess(TM), its restorative vascular access conduit
Devices FDA

HSMN NewsFeed - 15 Nov 2017
Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs
Devices Cardioloy Venture Capital

HSMN NewsFeed - 17 May 2017
Xeltis' Technology for Natural Heart Valve Restoration Featured as the Future of Valve Therapy at EuroPCR
Devices Interventional Cardiology

HSMN NewsFeed - 3 Oct 2016
First Heart Valve That Enables Cardiovascular Restoration Successfully Implanted in Three Patients in "Xplore-I" Clinical Trial
Devices Cardiology Regenerative Medicine

HSMN NewsFeed - 17 Dec 2015
Xeltis Extends Series B Financing to €30M, Signing Off Transformational Year
Devices Venture Capital

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.